FDA Adverse Event Injury Summary report: N

MCK PATELLOFEMORAL-L-SZ 4

MDR report key: 8329924 · Received February 11, 2019

Report

Report Number
3005985723-2019-00128
Event Type
Injury
Date Received
February 11, 2019
Date of Event
January 15, 2019
Report Date
April 26, 2019
Manufacturer
MAKO SURGICAL CORP.
Product Code
NPJ
UDI-DI
00848486000424
PMA / PMN Number
K090763
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

AN EVENT REGARDING PATIENT FACTORS INVOLVING A MAKO PATELLOFEMORAL COMPONENT WAS REPORTED. THE EVENT WAS NOT CONFIRMED. METHOD & RESULTS: -DEVICE EVALUATION AND RESULTS: NOT PERFORMED AS PRODUCT WAS NOT RETURNED -MEDICAL RECORDS RECEIVED AND EVALUATION: NO MEDICAL RECORDS WERE RECEIVED FOR REVIEW WITH A CLINICAL CONSULTANT. -DEVICE HISTORY REVIEW: ALL DEVICES WERE MANUFACTURED AND ACCEPTED INTO FINAL STOCK WITH NO RELEVANT REPORTED DISCREPANCIES. -COMPLAINT HISTORY REVIEW: THERE HAS BEEN NO OTHER SIMILAR EVENTS FOR THE REPORTED LOT. CONCLUSION: THE EVENT COULD NOT BE CONFIRMED NOR THE ROOT CAUSE DETERMINED BECAUSE THE DEVICES WERE NOT RETURNED FOR EVALUATION AND INSUFFICIENT MEDICAL INFORMATION WAS PROVIDED. IF THE DEVICES AND/OR ADDITIONAL INFORMATION ARE RECEIVED, THIS INVESTIGATION WILL BE REOPENED AND RE-EVALUATED.

Description of Event or Problem · 0

PATIENT UNDERWENT MAKO TKA REVISION FROM MAKO PF DUE TO PROGRESSIVE OA.

Additional Manufacturer Narrative · 1

IT WAS NOTED THAT THE DEVICE IS NOT AVAILABLE FOR EVALUATION. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, IT WILL BE PROVIDED IN A SUPPLEMENTAL REPORT UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

PATIENT UNDERWENT MAKO TKA REVISION FROM MAKO PF DUE TO PROGRESSIVE OA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
122268 MCK PATELLOFEMORAL-L-SZ 4 PROSTHESIS, KNEE PATELLOFEMOROTIBIAL, PARTIAL, SEMI-CONSTRAINED, CEMENTED, POLY NPJ MAKO SURGICAL CORP. 237407-1 00848486000424

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R